<![CDATA[GENMAB: Stærke data for Tisotumumab i livmoderhalskræft]]>Genmab Announces Very Favorable Topline Results from Phase 2 Clinical Trial of Tisotumab Vedotin in Recurrent or Metastatic Cervical Cancer.

https://ir.genmab.com/news-releases/news-release-details/genmab-announces-very-favorable-topline-results-phase-2-clinical

84873_23348500_genmab_prfoto3.jpg

]]>https://dev.proinvestor.com/forum/topic/441499/genmab-strke-data-for-tisotumumab-i-livmoderhalskrftRSS for NodeFri, 10 Jul 2026 10:37:45 GMTTue, 30 Jun 2020 02:20:28 GMT60